Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Antisense long non-coding RNA present novel mechanisms of cancer-gene regulation

EF 2016-17

Résumé
Lung cancer is a highly deadly form of cancer, with approximately 78 Canadians diagnosed every day. Only 17% of those diagnosed will survive longer than five years. This is due to the fact that over half of existing cases are the result of unknown molecular factors, despite major advances in understanding the molecular determinants of lung cancer. As such, current targeted therapies are only suitable for a small subset of patients harbouring known genetic drivers. Recent genomic sequencing improvements have revealed non-protein-coding RNA molecules (ncRNA) that play important roles in cancer development and regulation. A class of ncRNA, known as antisense long non-coding RNA (AS-lncRNA), is expressed from the DNA strand opposite protein-coding genes. AS-lncRNAs can negatively regulate their protein-coding partner genes, in some cases shutting them off completely. Interestingly in tumour cells, some AS-lncRNA levels have been shown to be vastly different from normal cells of the same tissue. This is particularly intriguing as the protein-coding partners of AS-lncRNAs can be genes with tumour suppressive or cancer-promoting function. We hypothesize that by allowing cancer-promoting genes to escape negative regulation or by the incorrect silencing of the production of tumour suppressors, these changes in AS-lncRNA levels may be a driver of lung cancer development. We propose to analyze AS-lncRNAs in lung cancer tissue and assess the biological consequences of their disruption in tumour cell models. This research will uncover a possible mechanism of tumour development in lung cancer, which may be harnessed for the design of new targeted therapies to improve the survival of lung cancer patients.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367327
Name
Sage Adam P
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Antisense long non-coding RNA present novel mechanisms of cancer-gene regulation
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antisense Rna; Bioinformatics; Cancer Genetics; Gene Regulation; Interdisciplinary Oncology; Long Non-Coding Rna; Lung Cancer; Molecular Drivers Of Cancer; Therapeutic Targets
Abstract
Lung cancer is a highly deadly form of cancer, with approximately 78 Canadians diagnosed every day. Only 17% of those diagnosed will survive longer than five years. This is due to the fact that over half of existing cases are the result of unknown molecular factors, despite major advances in understanding the molecular determinants of lung cancer. As such, current targeted therapies are only suitable for a small subset of patients harbouring known genetic drivers. Recent genomic sequencing improvements have revealed non-protein-coding RNA molecules (ncRNA) that play important roles in cancer development and regulation. A class of ncRNA, known as antisense long non-coding RNA (AS-lncRNA), is expressed from the DNA strand opposite protein-coding genes. AS-lncRNAs can negatively regulate their protein-coding partner genes, in some cases shutting them off completely. Interestingly in tumour cells, some AS-lncRNA levels have been shown to be vastly different from normal cells of the same tissue. This is particularly intriguing as the protein-coding partners of AS-lncRNAs can be genes with tumour suppressive or cancer-promoting function. We hypothesize that by allowing cancer-promoting genes to escape negative regulation or by the incorrect silencing of the production of tumour suppressors, these changes in AS-lncRNA levels may be a driver of lung cancer development. We propose to analyze AS-lncRNAs in lung cancer tissue and assess the biological consequences of their disruption in tumour cell models. This research will uncover a possible mechanism of tumour development in lung cancer, which may be harnessed for the design of new targeted therapies to improve the survival of lung cancer patients.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sage, Adam P
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~